On the first trading day of the Year of the Horse, the trend of share repurchases and increases in holdings by A-share listed companies continuesWallstreetcn·Feb 24 at 04:29 PM002511-0.40%300174+0.12%
JIUDIAN PHARMACEUTICAL and others establish an innovative pharmaceutical technology companyZhitong·Oct 29, 2025 at 10:40 PM300705+1.01%
JIUDIAN PHARMACEUTICAL released its performance for the first three quarters, with a net profit attributable to the parent company of 406 million yuan, a decrease of 9.64%Zhitong·Oct 29, 2025 at 05:10 AM300705+1.01%
JIUDIAN PHARMACEUTICAL established a ginseng e-commerce company in HunanZhitong·Oct 28, 2025 at 01:58 AM300705+1.01%
JIUDIAN PHARMACEUTICAL: Plans to use its own funds of 50 million yuan to jointly invest with Xiangjiang Shannuo and Jiu Zhi Qing Yan to establish Hunan Jiu Dian Shannuo Innovative Pharmaceutical Technology Co., LtdZhitong·Oct 23, 2025 at 04:30 AM300705+1.01%
JIUDIAN PHARMACEUTICAL has been approved to conduct clinical trials for two drugsZhitong·Sep 24, 2025 at 05:45 AM300705+1.01%
The chemical pharmaceutical sector rose in early trading, with SUNFLOWER hitting the daily limit of a 20cm increaseZhitong·Sep 21, 2025 at 08:36 PM688553+4.60%300705+1.01%
JIUDIAN PHARMACEUTICAL: The JIJ02 gel is expected to complete Phase I clinical trials in the first half of next yearZhitong·Sep 12, 2025 at 09:17 AM300705+1.01%
JIUDIAN PHARMACEUTICAL: The Phase III clinical trial report for Jiaoqi Pain Relief Gel Patch has been releasedZhitong·Sep 1, 2025 at 05:09 AM300705+1.01%
JIUDIAN PHARMACEUTICAL released its performance for the first half of the year, with a net profit attributable to the parent company of 291 million yuan, an increase of 2.57%Zhitong·Aug 22, 2025 at 03:35 AM300705+1.01%
JIUDIAN PHARMACEUTICAL: Acquired the Drug Clinical Trial Approval Notice through AssignmentZhitong·Aug 21, 2025 at 04:13 AM300705+1.01%
JIUDIAN PHARMACEUTICAL: Expected revenue growth of 10% to 20% year-on-year for the fiscal year 2025Zhitong·Aug 6, 2025 at 07:14 AM300705+1.01%
JIUDIAN PHARMACEUTICAL and others establish a new company in HunanZhitong·Jul 24, 2025 at 08:26 PM300705+1.01%
JIUDIAN PHARMACEUTICAL obtained a drug registration certificateZhitong·Jun 30, 2025 at 06:59 PM300705+1.01%
JIUDIAN PHARMACEUTICAL: PDX-04 has been approved to conduct clinical trials for pain relief in acute gout attacksZhitong·May 26, 2025 at 04:06 AM300705+1.01%
